These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9444544)

  • 1. Parkinson's disease worsened by nefazodone.
    Benazzi F
    Int J Geriatr Psychiatry; 1997 Dec; 12(12):1195. PubMed ID: 9444544
    [No Abstract]   [Full Text] [Related]  

  • 2. Toxic effects of nefazodone.
    Peak DA
    Ann Emerg Med; 1997 Oct; 30(4):551. PubMed ID: 9326874
    [No Abstract]   [Full Text] [Related]  

  • 3. Nefazodone withdrawal symptoms.
    Benazzi F
    Can J Psychiatry; 1998 Mar; 43(2):194-5. PubMed ID: 9533975
    [No Abstract]   [Full Text] [Related]  

  • 4. A case report of serotonin syndrome associated with combined nefazodone and fluoxetine.
    Smith DL; Wenegrat BG
    J Clin Psychiatry; 2000 Feb; 61(2):146. PubMed ID: 10732666
    [No Abstract]   [Full Text] [Related]  

  • 5. Serotonin syndrome from addition of low-dose trazodone to nefazodone.
    Margolese HC; Chouinard G
    Am J Psychiatry; 2000 Jun; 157(6):1022. PubMed ID: 10831493
    [No Abstract]   [Full Text] [Related]  

  • 6. Do serotonin reuptake inhibitor antidepressants worsen Parkinson's disease? A retrospective case series.
    Richard IH; Maughn A; Kurlan R
    Mov Disord; 1999 Jan; 14(1):155-7. PubMed ID: 9918360
    [No Abstract]   [Full Text] [Related]  

  • 7. Serotonin syndrome associated with nefazodone and paroxetine.
    John L; Perreault MM; Tao T; Blew PG
    Ann Emerg Med; 1997 Feb; 29(2):287-9. PubMed ID: 9018197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin syndrome associated with trazodone.
    Rao R
    Int J Geriatr Psychiatry; 1997 Jan; 12(1):129-30. PubMed ID: 9050436
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety and tolerability of the new antidepressants.
    Nelson JC
    J Clin Psychiatry; 1997; 58 Suppl 6():26-31. PubMed ID: 9227670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reassessment of nefazodone.
    Bryant SG
    Am J Health Syst Pharm; 1996 Oct; 53(19):2339-40, 2343. PubMed ID: 8893078
    [No Abstract]   [Full Text] [Related]  

  • 11. [Applications and safety of modern antidepressants in patients with liver diseases].
    Dubarek W; Kucia K
    Wiad Lek; 2007; 60(1-2):28-33. PubMed ID: 17607965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Parkinsonism and use of selective serotonin uptake inhibitors].
    Dietrichs E
    Tidsskr Nor Laegeforen; 2003 Apr; 123(7):947-8. PubMed ID: 12737071
    [No Abstract]   [Full Text] [Related]  

  • 13. Venlafaxine and nefazodone, two pharmacologically distinct antidepressants.
    Augustin BG; Cold JA; Jann MW
    Pharmacotherapy; 1997; 17(3):511-30. PubMed ID: 9165554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful management of depression with reboxetine in a patient who developed Parkinsonism related to paroxetine use.
    Kuloglu M; Caykoylu A; Ekinci O; Bayindirli D; Vural G; Deniz O
    J Psychopharmacol; 2010 Apr; 24(4):623-4. PubMed ID: 19074535
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials.
    Sussman N; Ginsberg DL; Bikoff J
    J Clin Psychiatry; 2001 Apr; 62(4):256-60. PubMed ID: 11379839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission of cancer chemotherapy-induced emesis during antidepressant therapy with nefazodone.
    Khouzam HR; Monteiro AJ; Gerken ME
    Psychosom Med; 1998; 60(1):89-91. PubMed ID: 9492245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone.
    Elliott AJ; Russo J; Bergam K; Claypoole K; Uldall KK; Roy-Byrne PP
    J Clin Psychiatry; 1999 Apr; 60(4):226-31. PubMed ID: 10221282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction.
    Feiger A; Kiev A; Shrivastava RK; Wisselink PG; Wilcox CS
    J Clin Psychiatry; 1996; 57 Suppl 2():53-62. PubMed ID: 8626364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse effect of nefazodone: hepatitis.
    Schrader GD; Roberts-Thompson IC
    Med J Aust; 1999 May; 170(9):452. PubMed ID: 10341782
    [No Abstract]   [Full Text] [Related]  

  • 20. SSRIs in depression: a decade of progress.
    Goldstein BJ
    J Psychopharmacol; 1998; 12(3 Suppl B):S3. PubMed ID: 9808076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.